About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Open Label Trial to Assess Iressa in Prostate Cancer Patients

NCT00635856·ClinicalTrials.gov

What this study is about

Take this into the appointment.

Saves the questions and what to expect into your notes, next to the visit they belong to.

Keep this study

Lead

AstraZeneca

Age

18–any

Sex

ALL

Healthy volunteers

Not accepted

You may be eligible if

Prostate cancer diagnosis
no evidence of metastasis
Age 18 or older

You may not be if

Prior chemotherapy for recurrent prostate cancer
Radiotherapy completed within 28 days of starting the study
Incomplete healing from prior cancer or other major surgery

The record

StatusCompleted

PhasePhase 2

Taking part100

StartedMay 2001

UpdatedApr 23, 2009

Conditions

Prostate Cancer

Clareo Health | Open Label Trial to Assess Iressa in Prostate Cancer Patients